Overview

A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomised, placebo-controlled study of the safety, tolerability and pharmacokinetics of single and multiple ascending oral doses of V81444 in healthy male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Vernalis (R&D) Ltd